Capital Fund Management »

Revance Therapeutics shares owned by Capital Fund Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $900k 79k 11.47
2023-06-30 $739k 29k 25.31
2022-12-31 $312k 17k 18.46
2020-09-30 $351k 14k 25.14